List of Excipients in API FEDRATINIB HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing FEDRATINIB HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Celgene Corporation | INREBIC | fedratinib hydrochloride | 59572-720 | CELLULOSE, MICROCRYSTALLINE | 2032-06-04 |
| Celgene Corporation | INREBIC | fedratinib hydrochloride | 59572-720 | FERRIC OXIDE RED | 2032-06-04 |
| Celgene Corporation | INREBIC | fedratinib hydrochloride | 59572-720 | GELATIN | 2032-06-04 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for FEDRATINIB HYDROCHLORIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
FEDRATINIB HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | fedratinib hydrochloride | 59572-720 |
| >Company | >Ingredient | >NDC |
FEDRATINIB HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
FEDRATINIB HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | fedratinib hydrochloride | 59572-720 |
| >Company | >Ingredient | >NDC |
FEDRATINIB HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
FEDRATINIB HYDROCHLORIDE drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | fedratinib hydrochloride | 59572-720 |
| >Company | >Ingredient | >NDC |
FEDRATINIB HYDROCHLORIDE drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
FEDRATINIB HYDROCHLORIDE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | fedratinib hydrochloride | 59572-720 |
| >Company | >Ingredient | >NDC |
FEDRATINIB HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
FEDRATINIB HYDROCHLORIDE drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | fedratinib hydrochloride | 59572-720 |
| >Company | >Ingredient | >NDC |
FEDRATINIB HYDROCHLORIDE drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
FEDRATINIB HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | fedratinib hydrochloride | 59572-720 |
| >Company | >Ingredient | >NDC |
FEDRATINIB HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch